Michel Detheux is the founder of ITeos Therapeutics. ITeos Therapeutics has raised $205M in total funding. Latest round: Series B.
Michel Detheux is the President and Chief Executive Officer at iTeos Therapeutics, a clinical-stage biopharmaceutical company he co-founded. The company is focused on discovering and developing novel immuno-oncology therapeutics to combat various cancers.
Full founder directory · Investor directory · Company funding database · Fundraising library